Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Dec 13, 1999
Company News
bioLeads board of directors update
...Drug discovery Appointed: Alfred Bach, CEO of BASF-Lynx AG, as chairman; Herbert-Ernst Finke, partner at
Hannover Finanz Group
...
Read More
BioCentury
|
Sep 27, 1999
Finance
Neuer Markt angst
...$6.9 million) in venture financing for its programs for lead discovery from biological sources from
Hannover Finanz Group
...
Read More
Items per page:
10
1 - 2 of 2
BioCentury
|
Dec 13, 1999
Company News
bioLeads board of directors update
...Drug discovery Appointed: Alfred Bach, CEO of BASF-Lynx AG, as chairman; Herbert-Ernst Finke, partner at
Hannover Finanz Group
...
Read More
BioCentury
|
Sep 27, 1999
Finance
Neuer Markt angst
...$6.9 million) in venture financing for its programs for lead discovery from biological sources from
Hannover Finanz Group
...
Read More
Items per page:
10
1 - 2 of 2
Previous page
Next page